These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21300094)

  • 1. Text message reminders to promote human papillomavirus vaccination.
    Kharbanda EO; Stockwell MS; Fox HW; Andres R; Lara M; Rickert VI
    Vaccine; 2011 Mar; 29(14):2537-41. PubMed ID: 21300094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents.
    Rand CM; Brill H; Albertin C; Humiston SG; Schaffer S; Shone LP; Blumkin AK; Szilagyi PG
    J Adolesc Health; 2015 May; 56(5 Suppl):S17-20. PubMed ID: 25863549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing HPV vaccination series completion rates via text message reminders.
    Matheson EC; Derouin A; Gagliano M; Thompson JA; Blood-Siegfried J
    J Pediatr Health Care; 2014; 28(4):e35-9. PubMed ID: 24200295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low rates of free human papillomavirus vaccine uptake among young women.
    Moore GR; Crosby RA; Young A; Charnigo R
    Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human papillomavirus vaccination in promoting delivery of other preventive and medical services.
    Kharbanda EO; Stockwell MS; Fox H; Ipp LS; Rickert VI
    Acad Pediatr; 2011; 11(4):326-32. PubMed ID: 21393081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic.
    Kouyoumdjian FG; Bailowitz A
    Pediatr Infect Dis J; 2011 Aug; 30(8):718-9. PubMed ID: 21343841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with completion of the human papillomavirus vaccine series.
    Neubrand TP; Breitkopf CR; Rupp R; Breitkopf D; Rosenthal SL
    Clin Pediatr (Phila); 2009 Nov; 48(9):966-9. PubMed ID: 19483128
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates.
    Al-Nuaimi NS; Al-Ghas YS; Al-Owais AH; Grivna M; Schneider J; Nagelkerke NJ; Bernsen RM
    Int J STD AIDS; 2011 Jul; 22(7):400-4. PubMed ID: 21729960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccine: an updated position statement of the Society for Adolescent Health and Medicine.
    Friedman L; Bell DL; Kahn JA; Marcell AV; Middleman AB; Rosenthal SL; Zimet GD
    J Adolesc Health; 2011 Feb; 48(2):215-6. PubMed ID: 21257124
    [No Abstract]   [Full Text] [Related]  

  • 11. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey.
    Tan J; Farrell L; Allen DG
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):472-7. PubMed ID: 21039383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who should get the HPV vaccine?
    Pichichero ME
    J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S;
    Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of human papillomavirus infection: provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Sep; 120(3):666-8. PubMed ID: 17766541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV vaccination recommended for 9- to 26-year-old male patients.
    AIDS Patient Care STDS; 2010 Aug; 24(8):531. PubMed ID: 20799387
    [No Abstract]   [Full Text] [Related]  

  • 18. Persuasive texts for prompting action: Agency assignment in HPV vaccination reminders.
    McGlone MS; Stephens KK; Rodriguez SA; Fernandez ME
    Vaccine; 2017 Aug; 35(34):4295-4297. PubMed ID: 28673483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccine among adult women: disparities in awareness and acceptance.
    Cui Y; Baldwin SB; Wiley DJ; Fielding JE
    Am J Prev Med; 2010 Dec; 39(6):559-63. PubMed ID: 21084077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.